Physician profile
Sally S Lee
NPI 1457468514
$4,889.41
in general payments reported to CMS, 2019-2025
22 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $250 · 2021: $594 · 2022: $1,105 · 2023: $977 · 2024: $416 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,130.71 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $979.97 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $605.72 | 2021-2024 | Cequa |
| Novartis Pharmaceuticals Corporation | $482.54 | 2019-2023 | |
| Allergan, INC. | $176.14 | 2020-2022 | |
| Shire North American Group INC | $172.42 | 2019 | |
| Aerie Pharmaceuticals, INC. | $162.57 | 2019-2021 | |
| Oyster Point Pharma, INC. | $158.20 | 2022 | |
| Abbvie INC. | $146.95 | 2022 | |
| Boston Scientific Corporation | $131.36 | 2023 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2019 | |
| Novo Nordisk INC | $124.79 | 2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $122.54 | 2024 | Airsupra |
| Glaukos Corporation | $116.67 | 2024 | Idose |
| Otsuka America Pharmaceutical, INC. | $95.81 | 2023 | Nuedexta |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $35.95 | 2021 | |
| Notal Vision, INC. | $29.89 | 2019 | |
| Optos, INC. | $23.97 | 2020 | |
| Celularity INC. | $22.85 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.62 | 2022 | |
| Alcon Vision LLC | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.